Utama › Kanser Endometrium › Florida

Kajian klinikal Kanser Endometrium di Florida

65 kajian untuk Kanser Endometrium sedang mencari peserta di lokasi di Florida.

Bandar di Florida

Teks kajian rasmi (Bahasa Inggeris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
dan 6 lagi

Mengambil pesertaFasa 2

Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Miami - Sylvester Comprehensive Cancer Center, Miami
Advent Health, Orlando
Florida Cancer Specialists South, Port Charlotte

Mengambil pesertaFasa 1/2

Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Sarasota Memorial Hospital-Venice, N. Venice
Florida Cancer Specialists - Sarasota Downtown, Sarasota
FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery, Sarasota
dan 3 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Mayo Clinic Florida, Jacksonville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07419841

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

AdventHealth Cancer Institute, Orlando

Mengambil pesertaFasa 1

Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

AdventHealth Medical Group Oncology Research at Celebration, Kissimmee

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Mayo Clinic in Florida, Jacksonville

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Mayo Clinic, Jacksonville
Genoma Research, Inc., Miami
Orlando Health, Orlando
dan 1 lagi

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05051722

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Sarasota
Avenzo Therapeutics Recruiting Site, Tampa

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05867251

DESTINY-PANTUMOUR04

Research Site, Coral Springs
Research Site, St. Petersburg
Research Site, West Palm Beach

Mengambil pesertaKajian pemerhatian

Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Jacksonville

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06218914

Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance

University of Miami, Miami

Mengambil pesertaFasa 2

Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT07594015

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

UM Sylvester Comprehensive Cancer Center at, Deerfield Beach
UM Sylvester Comprehensive Cancer Center at Doral, Doral
University of Florida, Gainesville
dan 9 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Florida Cancer Specialists, Sarasota
Moffitt Cancer Center and Research Institute, Tampa

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Moffitt, Tampa

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Omnicure Clinical Research, Doral
Bioresearch Partner, Hialeah
Florida Clinical Trials Group, Plantation
dan 1 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sylvester Comprehensive Cancer Center, Miami
Sara Cannon Research Institute Lake Nona, Orlando
Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Florida Cancer Specialists - South ( Site 7003), Fort Myers
UF Health Davis Cancer Pavilion and Shands Med Plaza ( Site 6026), Gainesville
Mount Sinai Braman Comprehensive Cancer Center ( Site 6031), Miami Beach
dan 3 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Wanita · Dikemas kini 17 Sep 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Florida Cancer Specialists - Lake Nona, Orlando

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07109726

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Broward Health Medical Center, Fort Lauderdale

Mengambil pesertaFasa 3

Umur 18 ke atas · Wanita · Dikemas kini 17 Sep 2026 · NCT06340568

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Memorial Healthcare System, Hollywood
The Oncology Institute of Hope & Innovation, Lakeland

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Miami, Miami
Sarah Cannon Research Institute - Lake Nona Florida, Orlando

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

SMH - Sarasota - Main Campus, Sarasota
Women's Care - 9th Ave, St. Petersburg
Women's Care - Armenia Ave, Tampa

Mengambil pesertaFasa 3

Umur 18 ke atas · Wanita · Dikemas kini 9 Sep 2026 · NCT07166094

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando

Mengambil pesertaFasa 1

Umur 18 ke atas · Wanita · Dikemas kini 3 Sep 2026 · NCT07755436

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Fort Myers
Research Site, Miami
Research Site, Miami Beach
dan 4 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Wanita · Dikemas kini 3 Sep 2026 · NCT06989112

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Florida Cancer Specialists, Orlando

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07186842

Endometrial Cancer Vaginal Fluid Specimen Collection Study

Physical Care Clinical Research, Sarasota

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Wanita · Dikemas kini 27 Ogo 2026 · NCT07544680

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

SCRI FCS Sarasota, Sarasota

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07383506

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Moffitt Cancer Center, Tampa

Mengambil pesertaFasa 1

Umur 15 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06276491

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Mount Sinai Comprehensive Cancer Center, Miami Beach

Mengambil pesertaFasa 2

Umur 18 ke atas · Wanita · Dikemas kini 21 Ogo 2026 · NCT05548296

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Mayo Clinic in Florida, Jacksonville

Mengambil pesertaFasa 1/2

Umur 16 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05269381

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

SCRI - Florida Cancer Specialists, Sarasota

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mayo Clinic, Jacksonville

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

AdventHealth Celebration, Celebration

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Miami Cancer Institute Baptist Health South Florida, Miami
ADVENTHEALTH (Data collection only), Orlando

Mengambil pesertaKajian pemerhatian

Umur 18 ke atas · Wanita · Dikemas kini 7 Ogo 2026 · NCT04291612

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Florida Cancer Specialists South, Fort Myers
USOR Florida Cancer Specialists North, St. Petersburg
USOR Florida Cancer Specialists East, West Palm Beach

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT05579366

Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma

University of Miami, Miami

Mengambil pesertaFasa 1

Umur 18 ke atas · Wanita · Dikemas kini 3 Ogo 2026 · NCT05603910

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Florida Cancer Specialists, Fort Myers
Mayo Clinic (Florida), Jacksonville
Cancer Specialists of North Florida, Jacksonville
dan 2 lagi

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Jul 2026 · NCT04657068

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.